Nano Vaccine For Hepatitis B Shows Promise For Third World; Nanoemulsion Could Save More Lives By Removing Current Vaccines’ Drawbacks, University of Michigan Study

This article was originally published here

EurekAlert — Chronic hepatitis B infects 400 million people worldwide, many of them children. Even with three effective vaccines available, hepatitis B remains a stubborn, unrelenting health problem, especially in Africa and other developing areas. The disease and its complications cause an estimated 1 million deaths globally each year.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply